featured
Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With APL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631
J. Clin. Oncol 2017 Aug 02;[EPub Ahead of Print], MA Kutny, TA Alonzo, RB Gerbing, YC Wang, SC Raimondi, BA Hirsch, CH Fu, S Meshinchi, AS Gamis, JH Feusner, JJ GregoryFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.